Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
41
|
pubmed:dateCreated |
1994-11-10
|
pubmed:abstractText |
Two- and three-dimensional (2D and 3D) NMR techniques have been used to assign the signals from nearly all of the protons in Lactobacillus casei dihydrofolate reductase (DHFR) (M(r) 18,300) in its 1:1 complex with the antibacterial drug trimethoprim. A sample of uniformly 15N-labeled protein was examined using 3D 15N/1H experiments [nuclear Overhauser, heteronuclear multiple quantum coherence (NOESY-HMQC) and total correlation, heteronuclear multiple quantum coherence (TOCSY-HMQC) experiments]. Twenty-two intermolecular NOEs between trimethoprim and protein protons and four intramolecular NOEs in the ligand have been detected. Some were obtained by using heteronuclear editing and 2D HMQC-NOESY experiments on complexes formed with 15N-and 13C-labeled trimethoprim molecules ([1,3-15N2,2-amino-15N]-and [7-13C,4'-methoxy-13C]trimethoprim) bound to unlabeled protein. The ligand-protein NOEs were used as distance constraints in conjunction with minimum energy and simulated annealing calculations (carried out with X-PLOR) to dock the trimethoprim ligand into dihydrofolate reductase, using as a starting structure the crystal coordinates from a related complex with a similar overall protein structure. The restrained minimum energy calculations and the simulated annealing calculations gave 83 calculated structures with distance violations of < 0.1 A. In all of these, the two aromatic rings of trimethoprim occupied essentially the same region of conformational space in the binding site (RMSD = 0.63 A). The protein residues nearest to the bound trimethoprim were found to be very similar in all of the structures and agreed well with corresponding contact residues observed in the X-ray crystal studies on trimethoprim complexes formed with Escherichia coli and chicken liver DHFRs.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
12416-26
|
pubmed:dateRevised |
2009-9-29
|
pubmed:meshHeading |
pubmed-meshheading:7918464-Amino Acid Sequence,
pubmed-meshheading:7918464-Animals,
pubmed-meshheading:7918464-Chickens,
pubmed-meshheading:7918464-Escherichia coli,
pubmed-meshheading:7918464-Hydrogen Bonding,
pubmed-meshheading:7918464-Lactobacillus casei,
pubmed-meshheading:7918464-Liver,
pubmed-meshheading:7918464-Magnetic Resonance Spectroscopy,
pubmed-meshheading:7918464-Methotrexate,
pubmed-meshheading:7918464-Models, Molecular,
pubmed-meshheading:7918464-Molecular Sequence Data,
pubmed-meshheading:7918464-Solutions,
pubmed-meshheading:7918464-Tetrahydrofolate Dehydrogenase,
pubmed-meshheading:7918464-Trimethoprim
|
pubmed:year |
1994
|
pubmed:articleTitle |
Solution structure of bound trimethoprim in its complex with Lactobacillus casei dihydrofolate reductase.
|
pubmed:affiliation |
Laboratory of Molecular Structure, National Institute for Medical Research, Mill Hill, London, U.K.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|